Evaluation of Endogenous Metabolic Markers of Hepatic CYP3A Activity Using Metabolic Profiling and Midazolam Clearance

MLA

Jang Ij, et al. “Evaluation of Endogenous Metabolic Markers of Hepatic CYP3A Activity Using Metabolic Profiling and Midazolam Clearance.” Clinical Pharmacology & Therapeutics, vol. 94, June 2013, pp. 601–09. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b4ecc4577bbeddbee494ffef54d8a270&authtype=sso&custid=ns315887.

APA

Jang Ij, Kyung Sang Yu, Joo Youn Cho, Kyoung-Soo Lim, Man Ho Choi, & Kwang-Hee Shin. (2013). Evaluation of Endogenous Metabolic Markers of Hepatic CYP3A Activity Using Metabolic Profiling and Midazolam Clearance. Clinical Pharmacology & Therapeutics, 94, 601–609.

Chicago

Jang Ij, Kyung Sang Yu, Joo Youn Cho, Kyoung-Soo Lim, Man Ho Choi, and Kwang-Hee Shin. 2013. “Evaluation of Endogenous Metabolic Markers of Hepatic CYP3A Activity Using Metabolic Profiling and Midazolam Clearance.” Clinical Pharmacology & Therapeutics 94 (June): 601–9. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b4ecc4577bbeddbee494ffef54d8a270&authtype=sso&custid=ns315887.